Prelude Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-201
| Closed | -$239K | – | 1334 |
|
|
2019
Q2 | $239K | Buy |
201
+25
| +14% | +$29.7K | 0.01% | 422 |
|
|
2019
Q1 | $219K | Buy |
176
+174
| +8,700% | +$217K | 0.01% | 426 |
|
|
2018
Q4 | $2K | Sell |
2
-3
| -60% | -$3K | ﹤0.01% | 1311 |
|
|
2018
Q3 | $8K | Buy |
5
+2
| +67% | +$3.2K | ﹤0.01% | 1163 |
|
|
2018
Q2 | $5K | Buy |
+3
| New | +$5K | ﹤0.01% | 1264 |
|